DK1027371T3 - Fremgangsmåde til fremstilling af höjvirusfrie thrombinkomponenter til dannelse af fibrinlim fra en pool af humant plasma - Google Patents

Fremgangsmåde til fremstilling af höjvirusfrie thrombinkomponenter til dannelse af fibrinlim fra en pool af humant plasma

Info

Publication number
DK1027371T3
DK1027371T3 DK98951133T DK98951133T DK1027371T3 DK 1027371 T3 DK1027371 T3 DK 1027371T3 DK 98951133 T DK98951133 T DK 98951133T DK 98951133 T DK98951133 T DK 98951133T DK 1027371 T3 DK1027371 T3 DK 1027371T3
Authority
DK
Denmark
Prior art keywords
viral
thrombin
recovery
pool
product
Prior art date
Application number
DK98951133T
Other languages
Danish (da)
English (en)
Inventor
Trung Bui-Khac
Original Assignee
Haemacure Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haemacure Corp filed Critical Haemacure Corp
Application granted granted Critical
Publication of DK1027371T3 publication Critical patent/DK1027371T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/022—Filtration
    • A61L2103/05—
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/908—Mechanical repair performed/surgical
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/92—Detection of biochemical

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK98951133T 1997-10-30 1998-10-29 Fremgangsmåde til fremstilling af höjvirusfrie thrombinkomponenter til dannelse af fibrinlim fra en pool af humant plasma DK1027371T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/960,660 US5981254A (en) 1997-10-30 1997-10-30 Process for producing thrombin from plasma

Publications (1)

Publication Number Publication Date
DK1027371T3 true DK1027371T3 (da) 2006-01-09

Family

ID=25503448

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98951133T DK1027371T3 (da) 1997-10-30 1998-10-29 Fremgangsmåde til fremstilling af höjvirusfrie thrombinkomponenter til dannelse af fibrinlim fra en pool af humant plasma

Country Status (16)

Country Link
US (1) US5981254A (cg-RX-API-DMAC10.html)
EP (1) EP1027371B1 (cg-RX-API-DMAC10.html)
JP (1) JP4278861B2 (cg-RX-API-DMAC10.html)
AT (1) ATE305011T1 (cg-RX-API-DMAC10.html)
AU (1) AU759145B2 (cg-RX-API-DMAC10.html)
CA (1) CA2307380A1 (cg-RX-API-DMAC10.html)
DE (1) DE69831684T2 (cg-RX-API-DMAC10.html)
DK (1) DK1027371T3 (cg-RX-API-DMAC10.html)
ES (1) ES2249843T3 (cg-RX-API-DMAC10.html)
IL (1) IL135812A (cg-RX-API-DMAC10.html)
IN (1) IN185759B (cg-RX-API-DMAC10.html)
NO (1) NO323299B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ504246A (cg-RX-API-DMAC10.html)
PL (1) PL194589B1 (cg-RX-API-DMAC10.html)
RU (1) RU2236237C2 (cg-RX-API-DMAC10.html)
WO (1) WO1999023111A1 (cg-RX-API-DMAC10.html)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT407484B (de) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
US6867285B2 (en) * 1999-12-20 2005-03-15 Mitsubishi Pharma Corporation Virus-free plasma protein compositions treated with porous membrane and process for producing the same
WO2001048016A1 (en) * 1999-12-23 2001-07-05 Csl Limited Separation of fibrinogen from plasma proteases
AU779126B2 (en) * 1999-12-23 2005-01-06 Csl Limited Separation of fibrinogen from plasma proteases
JP2002114799A (ja) * 2000-08-01 2002-04-16 Nihon Pharmaceutical Co Ltd ウイルス除去方法
US7411006B2 (en) 2000-10-23 2008-08-12 Shanbrom Technologies, Llc Enhanced production of blood clotting factors and fibrin fabric
US7365173B2 (en) * 2002-02-04 2008-04-29 American National Red Cross Method for the production of pure virally inactivated butyrylcholinesterase
DE10211632A1 (de) 2002-03-15 2003-10-09 Aventis Behring Gmbh Verfahren zur Abtrennung von Viren aus einer Proteinlösung durch Nanofiltration
US20060275829A1 (en) * 2002-04-15 2006-12-07 Hammond David J Combinatorial library for proteomic investigations
US20060275753A1 (en) * 2002-04-15 2006-12-07 Hammond David J Recovery of analytes using combinatorial libraries
US20070015230A1 (en) * 2002-04-15 2007-01-18 Hammond David J Identification and characterization of analytes from whole blood
CN100525829C (zh) * 2002-04-15 2009-08-12 美国国家红十字会 检测混合物中配体和靶标的方法
GB0216001D0 (en) 2002-07-10 2002-08-21 Nat Blood Authority Process and composition
ATE428440T1 (de) * 2002-07-23 2009-05-15 Bio & Bio Licensing Sa Thrombingenerierfähige und thrombinhaltige pharmazeutische wirkstoffzubereitungen und arzneimittel
ES2214967B1 (es) * 2003-03-06 2005-06-16 Probitas Pharma, S.A Procedimiento para la eliminacion de virus en soluciones de fibrinogeno y fibrinogeno obtenido por dicho procedimiento.
AU2004294403A1 (en) * 2003-12-01 2005-06-16 Novo Nordisk Health Care Ag Nanofiltration of factor VII solutions to remove virus
ES2395466T3 (es) * 2004-06-22 2013-02-12 Zymogenetics, Inc. Composiciones de trombina
DE102004044429B4 (de) * 2004-09-14 2009-04-30 Biotest Ag Verfahren zur Herstellung einer Zusammensetzung enthaltend von Willebrand Faktor
ES2226587B1 (es) * 2004-10-22 2005-12-16 Probitas Pharma, S.A. Composicion de trombina estable.
US20060270015A1 (en) * 2005-05-26 2006-11-30 Dan Pawlak Thrombin purification
FR2887883B1 (fr) 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
US20120195953A1 (en) * 2007-09-19 2012-08-02 Kieu Hoang Fibrin sealant (FIBRINGLURAAS) consisting of a kit of lyophilized high concentrate fribinogen intentionally enriched and preserved with fibronolysis inhibitor A1AT
RU2369410C1 (ru) * 2008-05-06 2009-10-10 Александр Николаевич Данилин Способ очистки биологической жидкости организма (крови) от вирусной инфекции путем сорбции на магнитоуправляемых наночастицах и устройство для его осуществления
GB0814570D0 (en) * 2008-08-08 2008-09-17 Diagnostics For The Real World Isolation of nucleic acid
US9011846B2 (en) 2011-05-02 2015-04-21 Biomet Biologics, Llc Thrombin isolated from blood and blood fractions
ES2664694T3 (es) * 2012-09-26 2018-04-23 Bone Therapeutics S.A. Composiciones que comprenden plasma tratado con solvente/detergente y ácido hialurónico para su uso en el tratamiento de trastornos musculoesqueléticos
RU2583931C2 (ru) * 2014-06-11 2016-05-10 Федеральное государственное бюджетное учреждение Гематологический научный центр Министерства здравоохранения РФ Способ получения концентрата тромбина
US9932388B2 (en) 2014-11-13 2018-04-03 Hemarus Therapeutics Limited Chromatographic process for producing high purity fibrinogen and thrombin
JP6666757B2 (ja) * 2016-03-10 2020-03-18 日本メジフィジックス株式会社 ポリオキシエチレン系非イオン界面活性剤の定量方法及び放射性医薬品製剤の製造方法
KR20200119818A (ko) * 2018-02-19 2020-10-20 바이엘 헬쓰케어 엘엘씨 변형된 필터 막 및 방법
WO2020229521A1 (en) 2019-05-14 2020-11-19 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for inhibiting or reducing bacterial biofilms on a surface
CN113754757B (zh) * 2021-07-01 2024-06-14 华兰生物工程股份有限公司 一种人纤维蛋白原的制备方法
EP4387993A1 (en) 2021-08-18 2024-06-26 Biotest AG Dry heat treatment of plasma-derived factor viii
KR20230121373A (ko) * 2022-02-11 2023-08-18 주식회사 녹십자 인자 xiii의 정제방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3843126C3 (de) * 1988-12-22 1994-10-06 Octapharma Ag Verfahren zur Herstellung eines hochreinen Thrombinkonzentrates
RU2030183C1 (ru) * 1989-07-13 1995-03-10 Наталья Юрьевна Шатковская Состав для соединения биопластических материалов в отохирургии
RU2049470C1 (ru) * 1990-04-20 1995-12-10 Новокузнецкий институт усовершенствования врачей Способ получения альфа-макроглобулина
FR2679251B1 (fr) * 1991-07-18 1993-11-12 Nord Assoc Essor Transfusion San Procede de preparation d'un concentre de thrombine humaine destine a un usage therapeutique.
US5395923A (en) * 1993-02-23 1995-03-07 Haemacure-Biotech, Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by "salting-out"
US5290918A (en) * 1993-02-23 1994-03-01 Haemacure Biotech Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by acidic precipitation
US5506127A (en) * 1994-09-21 1996-04-09 Proba; Zbigniew Therapeutic grade thrombin produced by chromatography
RU2062103C1 (ru) * 1994-09-29 1996-06-20 Московская медицинская академия им.И.М.Сеченова Способ получения концентрата фибриногена

Also Published As

Publication number Publication date
DE69831684D1 (de) 2006-02-02
RU2236237C2 (ru) 2004-09-20
PL340300A1 (en) 2001-01-29
CA2307380A1 (en) 1999-05-14
JP4278861B2 (ja) 2009-06-17
PL194589B1 (pl) 2007-06-29
NZ504246A (en) 2002-09-27
IN185759B (cg-RX-API-DMAC10.html) 2001-04-21
IL135812A0 (en) 2001-05-20
EP1027371A1 (en) 2000-08-16
IL135812A (en) 2007-09-20
NO20002293L (no) 2000-06-30
AU759145B2 (en) 2003-04-03
US5981254A (en) 1999-11-09
WO1999023111A1 (en) 1999-05-14
ES2249843T3 (es) 2006-04-01
EP1027371B1 (en) 2005-09-21
ATE305011T1 (de) 2005-10-15
NO20002293D0 (no) 2000-04-28
DE69831684T2 (de) 2006-06-22
JP2001521941A (ja) 2001-11-13
NO323299B1 (no) 2007-03-05
AU9731698A (en) 1999-05-24

Similar Documents

Publication Publication Date Title
DK1027371T3 (da) Fremgangsmåde til fremstilling af höjvirusfrie thrombinkomponenter til dannelse af fibrinlim fra en pool af humant plasma
US5328694A (en) Stable injectable solution of factor VIII
ATE553125T1 (de) Herstellung eines multimeren proteins durch zellfusionsverfahren
RU2000113224A (ru) Способ продуцирования в высокой степени вирусобезопасных компонентов для получения фибринового клея из пула плазмы человека
WO1997040864A1 (en) Method for making autologous fibrin sealant
NO963602D0 (no) Fremgangsmåte for å oppta et biologisk klebemiddel som er laget av konsentrerte koagulasjonsfaktorer ved utsalting
ATE324436T1 (de) Verfahren zur reinigung von menschlichen, dem papillomavirus ähnlichen partikeln.
DE3432083A1 (de) Pasteurisierte, isoagglutininfreie faktor viii-praeparation und verfahren zu ihrer herstellung
YU78402A (sh) Hemostatički aktivni preparat koji sadrži vwf i postupak njegovog pripremanja
SK22695A3 (en) Isolation and purification method of proteins dependent from vitamin k
NO307473B1 (no) Fremgangsmõte for fremstilling av et pasteurisert trombinkonsentrat
RU2006107533A (ru) Способ получения раствора альфа-1-антитрипсина
JPH05227983A (ja) 米糠蛋白誘導ペプチドの製造方法
DE3686390D1 (de) Verfahren zur herstellung vom antihaemophilfaktor (ahf) durch kaeltefaellung und zur verbesserung der loeslichkeit des hergestellten ahf-produktes.
JP3944267B2 (ja) プロトロンビンの活性化方法および該方法に基づくトロンビンの製造方法
BR9810242A (pt) Composições úteis como selante de fibrina
NO20000621D0 (no) FremgangsmÕte for fremstilling av kontrastmiddel
AU9647398A (en) Method for purifying thrombin substrates and/or inhibitors or method for eliminating the same
BR0005108A (pt) Processo para preparar um concentrado de composto e processar este concentrado
NO975005L (no) FremgangsmÕte for fremstilling av en vandig natriumhydroksydl÷sning
NO311662B1 (no) Fremgangsmåte for fremstilling av et virussikkert, terapeutisk, biologisk preparat fra humanplasma ved anvendelse avikke-ioniske tensider
DK234688D0 (da) 17beta-(cyclopropylamino)-androst-5-en-3beta-olderivater, deres fremstilling og anvendelse som laegemidler
DK59785A (da) Fremgangsmaade til fremstilling af i det vaesentlige fibrinogenfrit ahf
JPH10150980A (ja) プロトロンビンの精製方法
RU93006373A (ru) Способ получения щелочи цезия или рубидия и кислоты